BLOG

FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements

FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements

Sep 6, 2023

FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements | by: Sumeet Singh, Founder & Chairman | Article Posted: September 6, 2023 | Introduction The U.S. Food and Drug Administration (FDA) recently announced an extension on the...

Accreditation

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

FDA Authorizes Florida’s Drug Importation Program

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2024/01/Blog-Featured-Images-1600x880-3-100x55.png" alt="FDA Authorizes Florida’s Drug Importation Program" itemprop="image" class="left" />

FDA Authorizes Florida’s Drug Importation Program

January 9, 2024January 10, 2024

FDA Warning on Xylazine: Mitigating Human Risk

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-25-100x55.png" alt="FDA Warning on Xylazine: Mitigating Human Risk" itemprop="image" class="left" />

FDA Warning on Xylazine: Mitigating Human Risk

November 6, 2023November 6, 2023

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-24-100x55.png" alt="Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know " itemprop="image" class="left" />

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

November 6, 2023

FDA Authorizes Florida’s Drug Importation Program

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2024/01/Blog-Featured-Images-1600x880-3-100x55.png" alt="FDA Authorizes Florida’s Drug Importation Program" itemprop="image" class="left" />

FDA Authorizes Florida’s Drug Importation Program

January 9, 2024January 10, 2024

FDA Warning on Xylazine: Mitigating Human Risk

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-25-100x55.png" alt="FDA Warning on Xylazine: Mitigating Human Risk" itemprop="image" class="left" />

FDA Warning on Xylazine: Mitigating Human Risk

November 6, 2023November 6, 2023

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-24-100x55.png" alt="Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know " itemprop="image" class="left" />

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

November 6, 2023